Clinical Trial Update: The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) [Phase 3]

View source ↗

Summary

Phase 3 trial update for plecanatide in irritable bowel syndrome with constipation (IBS-C) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Plecanatide (plecanatide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Irritable Bowel Syndrome Characterized by Constipation | Phase 3 | Status: COMPLETED | Results posted: 2019-06-14